Role of Soy Supplementation in Prostate Cancer Development
Prostate Neoplasm
About this trial
This is an interventional prevention trial for Prostate Neoplasm focused on measuring Estrogen Receptor, Isoflavones, Prostate Neoplasm, Soy Supplementation
Eligibility Criteria
Inclusion Criteria: Histologically proven prostate cancer. Surgical candidate for prostatectomy. During study period, must agree not to take new supplements. No concurrent chemotherapy, radiation or hormonal therapy. No history of prior allergy to soy based products. Must not have been taking soy supplements or soy isoflavones within 90 days prior to study enrollment. Must be able to safely be on study supplements for period of at least two weeks prior to scheduled prostatectomy. Must give written and informed consent in accordance with institutional and federal guidelines. Exclusion Criteria: During study period, must agree not to take new supplements. No concurrent chemotherapy, radiation or hormonal therapy. No history of prior allergy to soy based products. Must not have been taking soy supplements or soy isoflavones within 90 days prior to study enrollment. Must be able to safely be on study supplements for period of at least two weeks prior to scheduled
Sites / Locations
- VA Medical Center, Kansas City MO
Arms of the Study
Arm 1
Arm 2
Placebo Comparator
Experimental
Arm Placebo
Arm Soy Supplement
Placebo
Soy Supplement